Leucadia National Corporation »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $25k 22k 1.12
2024-03-31 $1.6M 1.7M 0.97
2023-12-31 $9.4M 10M 0.93
2023-09-30 $4.0M 4.3M 0.94

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Golar Lng SHS (GLNG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Select Sector Spdr Tr Energy (XLE)
Visa Com Cl A (V)
Crowdstrike Hldgs Cl A (CRWD)
Freeport-mcmoran CL B (FCX)
Vaneck Etf Trust Gold Miners Etf (GDX)
Wal-Mart Stores (WMT)
Hillman Solutions Corp (HLMN)
Geron Corporation (GERN)

View all positions for Leucadia National Corporation

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1